Prelude, Onconova plan multimillion-dollar stock sales
January 11, 2021 at 13:21 PM EST
The stock sales are expected to bring in nearly $160 million combined for the companies, both of whom are developing cancer therapies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|